Radical Cystectomy in England from 2013 to 2019 on 12,644 patients: An analysis of national trends and comparison of surgical approaches using Hospital Episode Statistics data.
bladder cancer
complications
cost
outcomes
radical cystectomy
Journal
BJUI compass
ISSN: 2688-4526
Titre abrégé: BJUI Compass
Pays: United States
ID NLM: 101764975
Informations de publication
Date de publication:
Sep 2021
Sep 2021
Historique:
received:
17
01
2021
revised:
11
02
2021
accepted:
12
02
2021
entrez:
27
4
2022
pubmed:
28
4
2022
medline:
28
4
2022
Statut:
epublish
Résumé
We evaluate the data of 12,644 Radical Cystectomies in England (Open, Robotic and Laparoscopic) with trends in the adaption of techniques and post-operative complications. This analysis utilised national Hospital Episode Statistics (HES) from NHS England. There was a statistically significant increase ( This evaluation of the HES data from NHS England for 12,644 RC confirms an increase in the adoption of Robotic Cystectomy. Our data confirms the need to develop strategies with enhanced recovery protocols and post-operative close monitoring following Radical Cystectomy in order to reduce post-operative complications.
Identifiants
pubmed: 35474875
doi: 10.1002/bco2.79
pii: BCO279
pmc: PMC8988840
doi:
Types de publication
Journal Article
Langues
eng
Pagination
338-347Informations de copyright
© 2021 The Authors. BJUI Compass published by John Wiley & Sons Ltd on behalf of BJU International Company.
Déclaration de conflit d'intérêts
Nothing to disclose.
Références
J Robot Surg. 2019 Feb;13(1):129-140
pubmed: 29948875
J Urol. 2013 Feb;189(2):474-9
pubmed: 23017529
Urology. 2017 May;103:99-105
pubmed: 28214574
BMJ Open. 2018 Aug 8;8(8):e020500
pubmed: 30093510
BJU Int. 2003 Aug;92(3):232-6
pubmed: 12887473
Eur Urol. 2009 Jan;55(1):164-74
pubmed: 18675501
BMC Urol. 2019 Nov 8;19(1):110
pubmed: 31703573
BJUI Compass. 2021 Mar 12;2(5):338-347
pubmed: 35474875
Int J Urol. 2018 Mar;25(3):187-195
pubmed: 29178344
Eur Urol. 2015 Mar;67(3):363-75
pubmed: 25582930
Lancet. 2018 Jun 23;391(10139):2525-2536
pubmed: 29976469
Urol Oncol. 2018 Mar;36(3):88.e1-88.e9
pubmed: 29277584
BJU Int. 2019 Mar;123(3):380-382
pubmed: 30288913
Urol Oncol. 2016 Dec;34(12):532.e13-532.e19
pubmed: 27503783
Eur Urol. 2015 Jun;67(6):1042-1050
pubmed: 25496767
BJU Int. 2018 Jun;121(6):880-885
pubmed: 29359882
Eur Urol. 2014 Sep;66(3):569-76
pubmed: 24491306
Eur Urol. 2015 Mar;67(3):376-401
pubmed: 25560798
Investig Clin Urol. 2016 Jun;57 Suppl 1:S36-43
pubmed: 27326405
J Natl Compr Canc Netw. 2020 Mar;18(3):329-354
pubmed: 32135513
Eur Urol. 2014 Apr;65(4):778-92
pubmed: 24373477
Eur Urol. 2016 Apr;69(4):613-621
pubmed: 26272237
J Urol. 2017 Sep;198(3):552-559
pubmed: 28456635
Eur Urol. 2010 Feb;57(2):196-201
pubmed: 19853987
J Urol. 2011 Jun;185(6):2207-12
pubmed: 21497841
Urol Oncol. 2016 Oct;34(10):431.e9-431.e15
pubmed: 27264169
Eur Urol. 2012 Jun;61(6):1239-44
pubmed: 22482778
Eur Urol. 2017 Mar;71(3):462-475
pubmed: 27375033